Navigation Links
Wound Management Technologies Joins IMCO Vendor Network to Expand Sales Nationwide
Date:3/10/2009

FORT WORTH, Texas, March 10 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it has entered into a vendor agreement with Independent Medical Co-Op, Inc. (IMCO), the nation's premier association for medical product manufacturers and independent distributors.

IMCO vendors are carefully selected on quality, price, service, integrity and market acceptance, as well as their exceptional support for IMCO members and their customers. Only one of 20 vendors qualify to become an IMCO vendor. Wound Care Innovation's patented advanced wound care collagen product, CellerateRx(R), was selected as a unique product that has unprecedented capabilities and benefits through all phases of wound healing and is FDA cleared for use on all wound types, except for 3rd degree burns.

"As an IMCO vendor, Wound Care Innovations joins an elite growing network of independent distributors with over 1,000 sales people to market CellerateRx throughout the U.S.," said Cathy Bradshaw, president of Wound Care Innovations. "IMCO has grown into a major distribution force in the physician and nursing home markets, while expanding acute care and other market segments. We are excited with the new sales and marketing opportunities this new relationship brings to Wound Care Innovations."

About IMCO

Established in 1981, IMCO is a U.S. leader in medical supply distribution. The Company has established a trusted network of the best independent distributors in the healthcare industry. With over 125 member locations throughout North America, Puerto Rico and the US Virgin Islands, IMCO provides coverage in the Physician, Hospital, Blood Banks, Nursing Home, Lab, Industrial, Dental, Home Care, Government, EMS, and Veterinary markets.

For more information, visit www.imcoinc.com.

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. (OTCBB:WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company, please visit www.Celleraterx.com.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

    Contact:
    Product Information                             Shareholder Relations
    Cathy Bradshaw                                  Lucy Singleton
    President                                       Secretary
    954-315-9242                                    817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Association for the Advancement of Wound Care (AAWC) Leads Pressure Ulcer Care Initiative
2. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
3. Wound Care Certification Course Endorsed by the American College of Certified Wound Specialists
4. Smith & Nephew Announce the New RENASYS EZ(TM) System for Negative Pressure Wound Therapy
5. Wounded Warrior Projects Project Odyssey Aims to Teach Coping Skills for Combating Post-Traumatic Stress in Wounded Warriors
6. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
7. Regional Anesthesia Eases Wounded Soldiers Pain in Iraq and Afghanistan
8. Old Tech Helps Soldiers With New Wound Infection
9. Arobella Medical CEO Speaks at International Wound Care Conference in Paris
10. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
11. Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology: